These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 30350882

  • 1. Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements.
    Yang Y, Ding M, Di N, Azziz R, Yang D, Zhao X.
    J Clin Lab Anal; 2019 Mar; 33(3):e22699. PubMed ID: 30350882
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y, Ouyang N, Ye Y, Hu Q, Du T, Di N, Xu W, Azziz R, Yang D, Zhao X.
    Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of total testosterone and free androgen index measured by LC-MS/MS for PCOS and insulin resistance.
    Xu S, Liu Y, Xue K, Liu X, Jia G, Zeng Y, Chen Y.
    J Clin Lab Anal; 2022 Nov; 36(11):e24739. PubMed ID: 36258308
    [Abstract] [Full Text] [Related]

  • 4. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
    Ambroziak U, Kuryłowicz A, Kępczyńska-Nyk A, Bartoszewicz Z, Kondracka A, Jaźwiec R, Samborowska E, Dadlez M, Wysłouch-Cieszyńska A, Bednarczuk T.
    Ginekol Pol; 2017 Nov; 88(1):5-8. PubMed ID: 28157253
    [Abstract] [Full Text] [Related]

  • 5. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U, Ezeh C, Pisarska MD, Azziz R.
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, Rodríguez-Molina JM, Berrocal Sertucha MC, Aguilar Vilas MV.
    Endocrinol Nutr; 2014 Jun; 61(7):351-8. PubMed ID: 24680383
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK, Hong YS, Sung YA, Lee H.
    PLoS One; 2017 Jun; 12(5):e0178120. PubMed ID: 28542421
    [Abstract] [Full Text] [Related]

  • 8. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A, Pazderska A, Ahmed M, McGowan A, Phelan N, Boran G, Taylor AE, O'Reilly MW, Arlt W, Moore K, Behan LA, Sherlock M, Gibney J.
    Hum Reprod; 2018 Sep 01; 33(9):1727-1734. PubMed ID: 30020477
    [Abstract] [Full Text] [Related]

  • 9. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J, Hofer D, Trummer C, Ulbing M, Harger A, Pieber T, Owen L, Keevil B, Brabant G, Lerchbaum E, Obermayer-Pietsch B.
    J Clin Endocrinol Metab; 2015 Feb 01; 100(2):653-60. PubMed ID: 25387259
    [Abstract] [Full Text] [Related]

  • 10. Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome.
    Wen X, Wang L, Bai E.
    Front Endocrinol (Lausanne); 2024 Feb 01; 15():1370578. PubMed ID: 39109080
    [Abstract] [Full Text] [Related]

  • 11. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R, Kichler J, Calhoun M.
    Eur J Endocrinol; 2010 Jun 01; 162(6):1093-9. PubMed ID: 20371657
    [Abstract] [Full Text] [Related]

  • 12. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
    Salameh WA, Redor-Goldman MM, Clarke NJ, Mathur R, Azziz R, Reitz RE.
    Fertil Steril; 2014 Apr 01; 101(4):1135-1141.e2. PubMed ID: 24534279
    [Abstract] [Full Text] [Related]

  • 13. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Reprod Health; 2015 Jan 16; 12():7. PubMed ID: 25595199
    [Abstract] [Full Text] [Related]

  • 14. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 15. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A, Baş F, Yetim Ç, Uçar A, Poyrazoğlu Ş, Bundak R, Darendeliler F.
    Turk J Med Sci; 2019 Aug 08; 49(4):1117-1125. PubMed ID: 31286756
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia.
    Yildiz BO, Gedik O.
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec 10; 100(1):62-6. PubMed ID: 11728659
    [Abstract] [Full Text] [Related]

  • 17. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.
    Ann Endocrinol (Paris); 2015 Oct 10; 76(5):620-7. PubMed ID: 26514948
    [Abstract] [Full Text] [Related]

  • 18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 10; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 19. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO, Yarali H, Oguz H, Bayraktar M.
    J Clin Endocrinol Metab; 2003 May 10; 88(5):2031-6. PubMed ID: 12727950
    [Abstract] [Full Text] [Related]

  • 20. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, Repaci A, Ribichini D, Gambineri A.
    J Clin Endocrinol Metab; 2016 May 10; 101(5):2013-22. PubMed ID: 26964728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.